Do we underestimate VO2max in cancer survivors? Findings from a supramaximal verification test.

08:00 EDT 11th October 2019 | BioPortfolio

Summary of "Do we underestimate VO2max in cancer survivors? Findings from a supramaximal verification test."

Cancer survivors demonstrate a reduced maximal oxygen uptake (VO2max) which is clinically relevant in terms of overall survival. However, it remains uncertain whether they attain their true VO2max in a cardiopulmonary exercise test (CPET). In the present study, a supramaximal verification bout (Verif) was applied in cancer survivors to confirm attainment of VO2max. Seventy-five participants (61±12 years, n=43 females with breast cancer and n=32 males with prostate cancer, 6-52 weeks after primary therapy) performed a CPET on a cycle ergometer and a Verif at 110% peak power output. As verification criterion, VO2max in Verif should not exceed VO2max in CPET by >3%. On average, VO2max was significantly lower in Verif compared to CPET (1.60±0.38 l/min vs. 1.65±0.36 l/min, p=.023). On the individual level, n=51 (68%) satisfied the verification criterion, whereas n=24 (32%) demonstrated a higher VO2max in Verif. N=69 (92%) fulfilled ≥ 2 secondary criteria for maximal exhaustion in the CPET. While VO2max was not underestimated in the CPET on average, still one third of cancer survivors did not attain their true VO2max. Verif appears feasible and beneficial to confirm true VO2max in this population. Furthermore, it might be more reliable than secondary criteria for maximal exhaustion. Novelty bullets: • In about one third of cancer survivors, VO2max is underestimated by a CPET. • This underestimation of VO2max is not necessarily indicated by secondary criteria for maximal exhaustion. • A supramaximal verification bout appears feasible and helpful for the determination of VO2max in cancer survivors.


Journal Details

This article was published in the following journal.

Name: Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
ISSN: 1715-5320


DeepDyve research library

PubMed Articles [18327 Associated PubMed Articles listed on BioPortfolio]

Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients.

With advances in lung cancer treatments, the number of lung cancer survivors has increased. As cardiovascular diseases (CVD) are some of the major causes of non-cancer deaths, CVD management is an int...

Supportive Care and Information Needs of Cancer Survivors: A Comparison of Two Cohorts of Longterm Cancers Survivors 5 and 10 Years after Primary Cancer Diagnosis.

Addressing information and supportive care needs could enhance cancer survivors' ability to cope with the long-term and/or late effects of their disease. The study examines how long-term cancer surviv...


As the number of pediatric cancer survivors increases, so does our need to understand behavioral late effects. Prior studies show mixed results, with some noting increased emotional distress and psych...

HPV Vaccination Knowledge, Intentions, and Practices among Caregivers of Childhood Cancer Survivors.

The HPV vaccine is an important vaccine for childhood cancer survivors because of their risks of second cancers, yet few survivors receive it. We examined HPV vaccine knowledge among caregivers of chi...

Impact of immigration status on health behaviors and perceptions in cancer survivors.

Health behaviors including smoking cessation, physical activity (PA), and alcohol moderation are key aspects of cancer survivorship. Immigrants may have unique survivorship needs. We evaluated whether...

Clinical Trials [13052 Associated Clinical Trials listed on BioPortfolio]

Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

We are doing this study to learn more about colon and rectal cancer survivors. We want to know if survivors want more information about life after cancer. Do cancer survivors want to know ...

Adolescent Survivors of Cancer or Similar Illnesses

The purpose of this study is to examine the health behaviors of young adults who have been treated for cancer, leukemia, or similar illnesses. We will also ask you some questions about you...

Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.

This study aims to study the impact image guided radiotherapy with Cone beam CT will have on the outcomes(toxicities and response) of head and neck cancer when compared to 3D conformal rad...

Work Ability in Young Adult Survivors

To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.

Verification of Imaging System PCD-1000A

Scope Verification of technologies included in the PCD-1000A PET/CT imaging chain. - Define and confirm all supported clinical protocols - Evaluate performance

Medical and Biotech [MESH] Definitions

Persons who have experienced prolonged survival with or the following neoplastic disease and the impact of the disease on the individual, family members, and significant others.

Morphological findings useful in differentiation and classification of results in CYTODIAGNOSIS and related techniques.

An examination, review and verification of all financial accounts.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

Work that consists of a conference of physicians on their observations of a patient at the bedside, regarding the physical state, laboratory and other diagnostic findings, clinical manifestations, results of current therapy, etc. A clinical conference usually ends with a confirmation or correction of clinical findings by a pathological diagnosis performed by a pathologist. "Clinical conference" is often referred to as a "clinico-pathological conference."

Quick Search

DeepDyve research library

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Searches Linking to this Article